Regency Nephrocare Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 2.90 Cr
as on 17-12-2024
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 14.86%
(FY 2022)
- Profit 1787.53%
(FY 2022)
- Ebitda 41.37%
(FY 2022)
- Net Worth 32.04%
(FY 2022)
- Total Assets -13.62%
(FY 2022)
About Regency Nephrocare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 2.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Atul Kapoor, Abhishek Kapoor, Krishna Chellappa, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85191UP2013PTC058477
- Company No.
058477
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2013
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Regency Nephrocare?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Kapoor  | Director | 19-Dec-2014 | Current |
| Abhishek Kapoor | Director | 19-Jul-2013 | Current |
| Krishna Chellappa | Director | 16-Sep-2024 | Current |
| Rekha Daniel | Director | 11-May-2023 | Current |
| Anand Goyal | Director | 11-May-2023 | Current |
| Bhaskar Guha | Director | 11-May-2023 | Current |
Financial Performance and Corporate Structure Insights of Regency Nephrocare.
Regency Nephrocare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.86% increase. The company also saw a substantial improvement in profitability, with a 1787.53% increase in profit. The company's net worth Soared by an impressive increase of 32.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Regency Nephrocare?
In 2022, Regency Nephrocare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Srinath Nephrocare Private LimitedActive 12 years 19 daysRekha Daniel, Anand Goyal and 1 more are mutual person
Fresenius Medical Care India Private LimitedActive 18 years 9 monthsRekha Daniel, Anand Goyal and 1 more are mutual person
Fresenius Medical Care Dialysis Services India Private LimitedActive 13 years 11 monthsRekha Daniel, Anand Goyal and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Regency Nephrocare?
Regency Nephrocare has a workforce of 74 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Regency Nephrocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regency Nephrocare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
